Bedrijf laden
Keep exploring
The themes Johnson & Johnson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
- Samengesteld
Medical devices
Door InspectStocks · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
- Koers, 1 jaar
- +6,2%
- Omzet, 1 jaar
- +7,2%
+14A 8B 7C 3D 2
- Samengesteld
Big pharma
Door InspectStocks · 13 companies
The largest drugmakers, selling prescription medicines worldwide.
- Koers, 1 jaar
- +41,6%
- Omzet, 1 jaar
- +10,8%
+7A 7B 3C 3
Highest-graded in Drug Manufacturers General
Graded A or B and worth $2B or more: A first, then the largest.
- LLYELI Lilly And CompanyUS$ 1,36TA+
- MRKMerck & Co., Inc.US$ 364,3BA
- NVSNovartis AGUS$ 306,3BA
AMGNAmgen Inc.US$ 251,9BA+
GILDGilead Sciences, Inc.US$ 208,4BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 okt 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 okt 2026CAGraded C, now A
Hoe het geld verdient
- Innovative Medicine64%
- MedTech36%
De omzetaandelen zijn schattingen voor six months ended June 28, 2026, high confidence, geen cijfers uit een ingediend rapport.
Concurreert met
Wat het verkoopt6
DARZALEX
A medicine used to treat multiple myeloma, a cancer of plasma cells.
TREMFYA
A medicine for conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
CARVYKTI
A treatment made from a patient’s modified immune cells for multiple myeloma that has returned or has not responded to earlier treatment.
Nog 3 tonen
VARIPULSE
A system that uses pulsed electrical energy to treat atrial fibrillation, a disorder that causes an irregular heartbeat.
Impella
A heart pump used to support blood circulation in certain patients with heart failure or during high-risk heart procedures.
ACUVUE
A brand of contact lenses sold for vision correction.
Wie het koopt4
- Wholesalers, distributors and retailers that buy medicines and medical products for resale.
- Hospitals and clinics that buy medicines and devices for patient care and procedures.
- Physicians and other healthcare professionals who prescribe medicines or use medical devices in treatment.
- Eye-care professionals and retailers that supply contact lenses and other vision products.
Waar het op steunt, en wat het kan breken
Waar het bedrijf van afhangt
- 1Some medicines rely on licenses or partnerships with other companies. For example, a subsidiary licenses patent families related to DARZALEX from Genmab, and IMBRUVICA is co-commercialized in the United States with Pharmacyclics, an AbbVie company.
- 2The company depends on government approvals and ongoing oversight for its medicines and medical devices, including rules on safety, manufacturing, labeling and sales.
- 3Sales depend partly on health insurers and government programs deciding whether to cover products and how much they will reimburse; U.S. and other governments can also change medicine-pricing rules.
- 4The company uses third parties to make or supply some products and relies on complex international manufacturing and distribution chains.
Wat er mis kan gaan
- 1Generic and biosimilar competition can reduce sales of medicines when alternatives enter the market. The latest quarterly report describes continuing sales declines for STELARA and says biosimilar competition is also affecting other medicines.
- 2Government pricing rules, coverage decisions and reimbursement changes can affect what the company receives for medicines and medical devices. The company identifies U.S. drug-pricing measures and tighter regulation across markets as concerns.
- 3Lawsuits and product-safety claims can lead to substantial costs and affect sales or reputation. The latest quarterly report recorded charges related to talc litigation.
Over Johnson & Johnson
Johnson & Johnson develops, makes and sells prescription medicines and medical devices around the world. Its two businesses are Innovative Medicine, which sells medicines for conditions including cancer and immune disorders, and MedTech, which sells products used in heart procedures, surgery, orthopaedics and vision care.
- Hoofdkantoor
- New Brunswick, New Jersey
- Opgericht in
- 1887 (founding year, high confidence)
- Medewerkers
- 140,800 (December 28, 2025, high confidence)
- Genoteerd aan
- New York Stock Exchange
- Einde boekjaar
- Last Sunday in December
Gebouwd uit de eigen deponeringen van Johnson & Johnson bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.